v3.25.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders’ Equity
Shares of Beneficial Interest at Par Value
Additional Paid in Capital
Distributions in Excess of Net Income
Accumulated Other Comprehensive Loss
Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 31, 2023     87,867        
Beginning balance at Dec. 31, 2023 $ 1,154,350 $ 1,154,060 $ 879 $ 1,735,530 $ (569,391) $ (12,958) $ 290
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (3,647) (3,647)     (3,647)    
Unrealized gain on interest rate hedges 83 83       83  
Amortization of swap settlements 510 510       510  
Distributions to noncontrolling interests (2)           (2)
Dividends (15,885) (15,885)     (15,885)    
Share grants, net (in shares)     136        
Share grants, net 995 995 $ 1 994      
Ending balance (in shares) at Mar. 31, 2024     88,003        
Ending balance at Mar. 31, 2024 $ 1,136,404 1,136,116 $ 880 1,736,524 (588,923) (12,365) 288
Beginning balance (in shares) at Dec. 31, 2024 88,029   88,029        
Beginning balance at Dec. 31, 2024 $ 1,082,078 1,081,797 $ 880 1,740,078 (646,095) (13,066) 281
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (4,675) (4,675)     (4,675)    
Unrealized gain on interest rate hedges 89 89       89  
Amortization of swap settlements 510 510       510  
Distributions to noncontrolling interests (2)           (2)
Dividends (15,943) (15,943)     (15,943)    
Share grants, net (in shares)     128        
Share grants, net $ 1,144 1,144 $ 2 1,142      
Ending balance (in shares) at Mar. 31, 2025 88,157   88,157        
Ending balance at Mar. 31, 2025 $ 1,063,201 $ 1,062,922 $ 882 $ 1,741,220 $ (666,713) $ (12,467) $ 279